Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Can affordability and innovation coexist for medicines?

Colbert A, Rintoul A, Simão M, Hill S, Swaminathan S.

BMJ. 2020 Jan 13;368:l7058. doi: 10.1136/bmj.l7058. No abstract available.

2.

Symptom reporting, healthcare-seeking behaviour and antibiotic use for common infections: protocol for Bug Watch, a prospective community cohort study.

Smith CM, Conolly A, Fuller C, Hill S, Lorencatto F, Marcheselli F, Michie S, Mindell JS, Ridd MJ, Shallcross LJ, Tsakos G, Hayward A, Fragaszy EB.

BMJ Open. 2019 May 22;9(5):e028676. doi: 10.1136/bmjopen-2018-028676.

3.

Comparison of Sales Income and Research and Development Costs for FDA-Approved Cancer Drugs Sold by Originator Drug Companies.

Tay-Teo K, Ilbawi A, Hill SR.

JAMA Netw Open. 2019 Jan 4;2(1):e186875. doi: 10.1001/jamanetworkopen.2018.6875.

4.

A global accountability mechanism for access to essential medicines.

Simão M, Wirtz VJ, Al-Ansary LA, Hill S, Grove J, Gray AL, Nannei C, Hedman L, Das P, Hogerzeil H.

Lancet. 2018 Dec 8;392(10163):2418-2420. doi: 10.1016/S0140-6736(18)32986-6. No abstract available.

PMID:
30527401
5.

Beliefs about Sexual Assault in India and Britain are Explained by Attitudes Toward Women and Hostile Sexism.

Hill S, Marshall TC.

Sex Roles. 2018;79(7):421-430. doi: 10.1007/s11199-017-0880-6. Epub 2018 Jan 6.

6.

Making diagnostic tests as essential as medicines.

Velazquez Berumen A, Garner S, Hill SR, Swaminathan S.

BMJ Glob Health. 2018 Aug 3;3(4):e001033. doi: 10.1136/bmjgh-2018-001033. eCollection 2018. No abstract available.

7.

The drugs don't work: WHO's role in advancing new antibiotics.

Beyer P, Moorthy V, Paulin S, Hill SR, Sprenger M, Garner S, Simão M, Guerra R, Magrini N, Swaminathan S.

Lancet. 2018 Jul 28;392(10144):264-266. doi: 10.1016/S0140-6736(18)31570-8. No abstract available.

PMID:
30064640
8.

Value-Based Pricing: L'Enfant Terrible?

Garner S, Rintoul A, Hill SR.

Pharmacoeconomics. 2018 Jan;36(1):5-6. doi: 10.1007/s40273-017-0567-4. No abstract available.

9.

Cost-effectiveness thresholds: pros and cons.

Bertram MY, Lauer JA, De Joncheere K, Edejer T, Hutubessy R, Kieny MP, Hill SR.

Bull World Health Organ. 2016 Dec 1;94(12):925-930. Epub 2016 Sep 19.

10.

Clarifying WHO's position on the FRAX® tool for fracture prediction.

Ford N, Norris SL, Hill SR.

Bull World Health Organ. 2016 Dec 1;94(12):862. No abstract available.

11.

Towards access 2030.

Hill S, Kieny MP.

Lancet. 2017 Jan 28;389(10067):341-343. doi: 10.1016/S0140-6736(16)31904-3. Epub 2016 Nov 8. No abstract available.

PMID:
27832875
12.

Medicine shortages: a commentary on causes and mitigation strategies.

Iyengar S, Hedman L, Forte G, Hill S.

BMC Med. 2016 Sep 29;14(1):124.

13.

Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis.

Iyengar S, Tay-Teo K, Vogler S, Beyer P, Wiktor S, de Joncheere K, Hill S.

PLoS Med. 2016 May 31;13(5):e1002032. doi: 10.1371/journal.pmed.1002032. eCollection 2016 May.

14.

Expensive medicines: ensuring objective appraisal and equitable access.

Hill SR, Bero L, McColl G, Roughead E.

Bull World Health Organ. 2015 Jan 1;93(1):4. doi: 10.2471/BLT.14.148924. No abstract available.

15.
16.

Fair and reasonable judgments of cost-effectiveness of medicines.

Olson LG, Hill SR.

Trends Pharmacol Sci. 2014 Dec;35(12):628-9. doi: 10.1016/j.tips.2014.09.009. No abstract available.

PMID:
25441932
17.

NICE, social values, and balancing objectivity and equity.

Hill SR, Olson LG.

Pharmacoeconomics. 2014 Nov;32(11):1039-41. doi: 10.1007/s40273-014-0220-4. No abstract available.

PMID:
25249201
18.

Expanding disease definitions in guidelines and expert panel ties to industry: a cross-sectional study of common conditions in the United States.

Moynihan RN, Cooke GP, Doust JA, Bero L, Hill S, Glasziou PP.

PLoS Med. 2013 Aug;10(8):e1001500. doi: 10.1371/journal.pmed.1001500. Epub 2013 Aug 13.

19.

Developing and Evaluating Communication Strategies to Support Informed Decisions and Practice Based on Evidence (DECIDE): protocol and preliminary results.

Treweek S, Oxman AD, Alderson P, Bossuyt PM, Brandt L, Brożek J, Davoli M, Flottorp S, Harbour R, Hill S, Liberati A, Liira H, Schünemann HJ, Rosenbaum S, Thornton J, Vandvik PO, Alonso-Coello P; DECIDE Consortium.

Implement Sci. 2013 Jan 9;8:6. doi: 10.1186/1748-5908-8-6.

20.

Moving from evidence to developing recommendations in guidelines: article 11 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.

Schünemann HJ, Oxman AD, Akl EA, Brozek JL, Montori VM, Heffner J, Hill S, Woodhead M, Campos-Outcalt D, Alderson P, Woitalla T, Puhan MA, Falck-Ytter Y, Bousquet J, Guyatt G; ATS/ERS Ad Hoc Committee on Integrating and Coordinating Efforts in COPD Guideline Development.

Proc Am Thorac Soc. 2012 Dec;9(5):282-92. doi: 10.1513/pats.201208-064ST. Review.

PMID:
23256172
21.

Incorporating considerations of cost-effectiveness, affordability, and resource implications in guideline development: article 6 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.

Hill SR, Olson LG, Falck-Ytter Y, Cruz AA, Atkins D, Baumann M, Jaeschke R, Woitalla T, Schünemann HJ; ATS/ERS Ad Hoc Committee on Integrating and Coordinating Efforts in COPD Guideline Development.

Proc Am Thorac Soc. 2012 Dec;9(5):251-5. doi: 10.1513/pats.201208-059ST. Review.

PMID:
23256167
22.

Barriers and facilitators to the implementation of clinical practice guidelines: a cross-sectional survey among physicians in Estonia.

Taba P, Rosenthal M, Habicht J, Tarien H, Mathiesen M, Hill S, Bero L.

BMC Health Serv Res. 2012 Dec 13;12:455. doi: 10.1186/1472-6963-12-455.

23.

The updated clinical guideline development process in Estonia is an efficient method for developing evidence-based guidelines.

Bero LA, Hill S, Habicht J, Mathiesen M, Starkopf J.

J Clin Epidemiol. 2013 Feb;66(2):132-9. doi: 10.1016/j.jclinepi.2012.07.007. Epub 2012 Sep 10. Review.

PMID:
22974497
24.

GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence.

Brunetti M, Shemilt I, Pregno S, Vale L, Oxman AD, Lord J, Sisk J, Ruiz F, Hill S, Guyatt GH, Jaeschke R, Helfand M, Harbour R, Davoli M, Amato L, Liberati A, Schünemann HJ.

J Clin Epidemiol. 2013 Feb;66(2):140-50. doi: 10.1016/j.jclinepi.2012.04.012. Epub 2012 Aug 3. Review.

PMID:
22863410
25.

Priority medicines for maternal and child health: a global survey of national essential medicines lists.

Hill S, Yang A, Bero L.

PLoS One. 2012;7(5):e38055. doi: 10.1371/journal.pone.0038055. Epub 2012 May 31.

26.

Putting the priorities first: medicines for maternal and child health.

Hill SR.

Bull World Health Organ. 2012 Mar 1;90(3):236-8. doi: 10.2471/BLT.11.088658. Epub 2011 Dec 5. No abstract available.

27.

Mapping the availability, price, and affordability of antiepileptic drugs in 46 countries.

Cameron A, Bansal A, Dua T, Hill SR, Moshe SL, Mantel-Teeuwisse AK, Saxena S.

Epilepsia. 2012 Jun;53(6):962-9. doi: 10.1111/j.1528-1167.2012.03446.x. Epub 2012 Mar 20.

28.

Cost-effectiveness analysis for clinicians.

Hill SR.

BMC Med. 2012 Feb 1;10:10. doi: 10.1186/1741-7015-10-10.

29.

Characteristics and quality of reporting of cluster randomized trials in children: reporting needs improvement.

Walleser S, Hill SR, Bero LA.

J Clin Epidemiol. 2011 Dec;64(12):1331-40. doi: 10.1016/j.jclinepi.2011.04.006. Epub 2011 Jul 20. Review.

PMID:
21775103
30.

Identifying barriers to the availability and use of Magnesium Sulphate Injection in resource poor countries: a case study in Zambia.

Ridge AL, Bero LA, Hill SR.

BMC Health Serv Res. 2010 Dec 16;10:340. doi: 10.1186/1472-6963-10-340.

31.

To give is better than to receive: compliance with WHO guidelines for drug donations during 2000-2008.

Bero L, Carson B, Moller H, Hill S.

Bull World Health Organ. 2010 Dec 1;88(12):922-9. doi: 10.2471/BLT.10.079764. Epub 2010 Aug 27.

32.

The GRADE approach and Bradford Hill's criteria for causation.

Schünemann H, Hill S, Guyatt G, Akl EA, Ahmed F.

J Epidemiol Community Health. 2011 May;65(5):392-5. doi: 10.1136/jech.2010.119933. Epub 2010 Oct 14.

PMID:
20947872
33.

Challenges in developing evidence-based recommendations using the GRADE approach: the case of mental, neurological, and substance use disorders.

Barbui C, Dua T, van Ommeren M, Yasamy MT, Fleischmann A, Clark N, Thornicroft G, Hill S, Saxena S.

PLoS Med. 2010 Aug 31;7(8). pii: e1000322. doi: 10.1371/journal.pmed.1000322. No abstract available.

34.

CONSORT 2010.

Saint-Raymond A, Hill S, Martines J, Bahl R, Fontaine O, Bero L.

Lancet. 2010 Jul 24;376(9737):229-30. doi: 10.1016/S0140-6736(10)61134-8. No abstract available.

PMID:
20656114
35.

Antiepileptic drugs in children in developing countries: research and treatment guideline needs.

Farkhondeh M, Hill SR, Cross JH, Dua T.

Epilepsia. 2009 Nov;50(11):2340-3. doi: 10.1111/j.1528-1167.2009.02301.x. Epub 2009 Sep 10.

36.
37.

What essential medicines for children are on the shelf?

Robertson J, Forte G, Trapsida JM, Hill S.

Bull World Health Organ. 2009 Mar;87(3):231-7.

38.

Children and tuberculosis medicines: bridging the research gap.

Hill S, Regondi I, Grzemska M, Matiru R.

Bull World Health Organ. 2008 Sep;86(9):658. No abstract available.

39.

The role of value for money in public insurance coverage decisions for drugs in Australia: a retrospective analysis 1994-2004.

Harris AH, Hill SR, Chin G, Li JJ, Walkom E.

Med Decis Making. 2008 Sep-Oct;28(5):713-22. doi: 10.1177/0272989X08315247. Epub 2008 Mar 31.

PMID:
18378939
40.

Setting standards for essential children's medicines.

Hill SR, Gray A, Weber M.

Bull World Health Organ. 2007 Sep;85(9):650. No abstract available.

41.

Saving womens lives: evidence-based recommendations for the prevention of postpartum haemorrhage.

Mathai M, Gülmezoglu AM, Hill S.

Bull World Health Organ. 2007 Apr;85(4):322-3. No abstract available.

42.

Transparent development of the WHO rapid advice guidelines.

Schünemann HJ, Hill SR, Kakad M, Vist GE, Bellamy R, Stockman L, Wisløff TF, Del Mar C, Hayden F, Uyeki TM, Farrar J, Yazdanpanah Y, Zucker H, Beigel J, Chotpitayasunondh T, Hien TT, Ozbay B, Sugaya N, Oxman AD.

PLoS Med. 2007 May;4(5):e119.

43.

Leading by example: a culture change at WHO.

Hill S, Pang T.

Lancet. 2007 Jun 2;369(9576):1842-1844. doi: 10.1016/S0140-6736(07)60676-X. No abstract available.

PMID:
17493675
44.

Medicines prices and Malaysia--untangling the medicines web.

Hill S.

PLoS Med. 2007 Mar 27;4(3):e149. No abstract available.

45.

What drives health-care spending priorities? An international survey of health-care professionals.

Salkeld G, Henry D, Hill S, Lang D, Freemantle N, D'Assunção J.

PLoS Med. 2007 Feb;4(2):e94. No abstract available.

46.

WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus.

Schünemann HJ, Hill SR, Kakad M, Bellamy R, Uyeki TM, Hayden FG, Yazdanpanah Y, Beigel J, Chotpitayasunondh T, Del Mar C, Farrar J, Tran TH, Ozbay B, Sugaya N, Fukuda K, Shindo N, Stockman L, Vist GE, Croisier A, Nagjdaliyev A, Roth C, Thomson G, Zucker H, Oxman AD; WHO Rapid Advice Guideline Panel on Avian Influenza.

Lancet Infect Dis. 2007 Jan;7(1):21-31. Review.

PMID:
17182341
47.

Boosting access to essential medicines for children.

Hogerzeil HV, Hill S, Rago L.

Lancet. 2006 Oct 21;368(9545):1419. No abstract available.

PMID:
17055942
48.

Response rate or time to progression as predictors of survival in trials of metastatic colorectal cancer or non-small-cell lung cancer: a meta-analysis.

Johnson KR, Ringland C, Stokes BJ, Anthony DM, Freemantle N, Irs A, Hill SR, Ward RL.

Lancet Oncol. 2006 Sep;7(9):741-6.

PMID:
16945769
49.

Ties that bind: multiple relationships between clinical researchers and the pharmaceutical industry.

Henry D, Doran E, Kerridge I, Hill S, McNeill PM, Day R.

Arch Intern Med. 2005 Nov 28;165(21):2493-6.

PMID:
16314546
50.

Drug prices and value for money: the Australian Pharmaceutical Benefits Scheme.

Henry DA, Hill SR, Harris A.

JAMA. 2005 Nov 23;294(20):2630-2. No abstract available.

PMID:
16304078

Supplemental Content

Loading ...
Support Center